Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report) saw a significant increase in short interest in the month of July. As of July 31st, there was short interest totaling 452,300 shares, anincreaseof43.3% from the July 15th total of 315,600 shares. Currently,0.0% of the company's shares are sold short. Based on an average daily trading volume, of 626,700 shares, the short-interest ratio is currently 0.7 days. Based on an average daily trading volume, of 626,700 shares, the short-interest ratio is currently 0.7 days. Currently,0.0% of the company's shares are sold short.
Reckitt Benckiser Group Price Performance
OTCMKTS:RBGLY remained flat at $15.20 on Friday. The company's stock had a trading volume of 238,691 shares, compared to its average volume of 261,166. The company's 50 day moving average price is $14.30 and its two-hundred day moving average price is $13.62. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.37 and a current ratio of 0.56. Reckitt Benckiser Group has a 1-year low of $10.95 and a 1-year high of $15.26.
Reckitt Benckiser Group Cuts Dividend
The company also recently declared a dividend, which will be paid on Thursday, September 25th. Shareholders of record on Monday, August 11th will be issued a $0.2106 dividend. The ex-dividend date is Friday, August 8th. This represents a yield of 341.0%.
Analyst Ratings Changes
Several equities research analysts have recently weighed in on RBGLY shares. Sanford C. Bernstein raised Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a research note on Thursday, June 5th. Royal Bank Of Canada reissued an "outperform" rating on shares of Reckitt Benckiser Group in a research note on Friday, July 25th. Four research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Buy".
Get Our Latest Report on Reckitt Benckiser Group
About Reckitt Benckiser Group
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Read More
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.